back to homepage

Regulatory News

Doctors Group Sues FDA, Saying Drug Does More Harm Than Good

LOS ANGELES (CN) – A physicians group sued the U.S. FDA, seeking revocation of FDA approval of roflumilast, a drug used to treat chronic obstructive pulmonary disease. The drug, whose

Read More

New Disclosure & Privacy Rules Challenge Biomedical Research Operations

The long wait is finally over for much-anticipated regulations governing disclosure of pharmaceutical company payments to physicians, and on the rights of patients to protect access to their personal health

Read More

Things to Know About the Latest Final Interim Rules to Patent Term Adjustment

The U.S. Patent and Trademark Office (USPTO) published interim final rules revising several patent term adjustment (PTA) provisions in view of the AIA Technical Corrections Act of January 14, 2013.

Read More